{"id":2187,"date":"2025-10-23T09:51:14","date_gmt":"2025-10-23T01:51:14","guid":{"rendered":"https:\/\/sg-apics.com\/?page_id=2187"},"modified":"2026-07-09T13:47:41","modified_gmt":"2026-07-09T05:47:41","slug":"exhibitors","status":"publish","type":"page","link":"https:\/\/sg-apics.com\/2026\/exhibitors\/","title":{"rendered":"EXHIBITORS"},"content":{"rendered":"

EXHIBITORS<\/h2><\/div><\/div><\/div><\/div><\/div>\n
<\/div>
<\/span><\/div><\/div><\/div>

Aerogen Ltd (Booth No: C05)<\/h4><\/div>

Aerogen is a world leader in acute care aerosol drug delivery. Aerogen technology has been in use for over 25 years, in more than 80 countries globally and is associated with over 200 clinical papers and publications.1<\/sup> Aerogen vibrating mesh nebuliser technology has been used to treat 30 million patients in more than 80 countries worldwide.1<\/sup><\/p>\n

Aerogen is the partner of choice for the world\u2019s leading ventilator companies for aerosol drug delivery.1<\/sup> The company continues to leverage their expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes.<\/p>\n

From critical care to emergency care, and across multiple ventilated and non-ventilated therapies, discover how Aerogen facilitates aerosol drug delivery at every stage of your patient\u2019s respiratory therapy journey.2<\/sup><\/p>\n

For more information, please visit: www.aerogen.com<\/a><\/p>\n

References<\/p>\n

    \n
  1. Aerogen Data on File<\/span><\/li>\n
  2. 30-354 REV U Aerogen Solo Instruction Manual<\/span><\/li>\n<\/ol>\n<\/div><\/div><\/div>
    <\/div><\/div><\/div><\/div><\/div>
    <\/div>
    <\/span><\/div><\/div><\/div>

    Aitrics (Booth No: B02)<\/h4><\/div>

    Aitrics, established in 2016 by medical professionals from Severance Hospital and professors from KAIST, specialises in AI-based medical intelligence.<\/p>\n

    Aitrics-VC(VitalCare) offers an advanced AI solution that predicts patient deterioration at early stages. Utilising 19 types of EMR data\u2014vital signs(6), blood tests(11), GCS and age\u2014 It provides precise detection of abnormal signs.<\/p>\n

    Aitrics-VC is adept at predicting:<\/p>\n

      \n
    1. The risk of sepsis in general wards within 4 hours.<\/li>\n
    2. The risk of major adverse events (mortality, unexpected ICU transfers, CPR) in general wards within 6 hours.<\/li>\n
    3. The risk of mortality in ICU within 6 hours.<\/li>\n<\/ol>\n

      By forecasting potential emergencies in hospitals, it assists healthcare professionals in providing timely treatment, thereby reducing patient mortality. It also enhances operational efficiency by preventing the wastage of resources caused by false alarms.<\/p>\n

      For more information, please visit: www.aitrics.com\/kr\/ <\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Ambu (Booth No: A03)<\/h4><\/div>

      Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety, and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions.<\/p>\n

      We are driven by our strong purpose: Together, we rethink solutions to save lives and improve patient care. <\/strong><\/p>\n

      From the world’s first self-inflating resuscitation bag to the latest innovations for anaesthesiologists and airway management professionals, Ambu continuously looks for ways to help you save lives and improve patient care.<\/p>\n

      We take pride in our comprehensive range of airway and anaesthesia products. From one of our key products, Ambu\u00ae AuraGain\u2122 Laryngeal Mask, offering superior seal and airway management, to Ambu\u00ae aScope\u2122 4 Broncho Series, which offers the portability and essential performance needed for procedures ranging from intubations and thoracic anaesthesia, are sterile, always available, and part of an integrated solution that improves safety, workflow, and productivity.<\/p>\n

      Ambu\u2019s history of resuscitator innovation stretches back over 65 years to the release of the original Ambu bag. Today, the Ambu\u00ae Spur II\u2122 Disposable Resuscitator represents Ambu\u2019s latest development in resuscitators. It stands as a reliable choice for manual ventilation in emergency situations, ensuring prompt and effective respiratory support. Additionally, we have our Ambu\u00ae King Mask\u2122, which is an anatomically shaped, disposable anaesthetic facemask that is designed to support a tight seal around the facial anatomy with minimal pressure to the face. The King Mask range can be used for infant, paediatric, and adult patients.<\/p>\n

      Working with Sustainability: The Ambu Way<\/strong><\/p>\n

      At Ambu, sustainability considerations are an integral part of our business activities. For instance, the way we work with the environment is guided by a number of ambitious sustainability targets and continuously monitored environmental and climate indicators. Moreover, we review our suppliers and their products with regard to environmental and social aspects during the total life-cycle of the products.<\/p>\n

      For more information, please visit www.ambu.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Dr\u00e4ger (Booth No: A01)<\/h4><\/div>

      Dr\u00e4ger is an international leader in the fields of medical and safety technology. The family-owned company was founded in L\u00fcbeck, Germany, in 1889. Over the past five generations, Dr\u00e4ger has evolved into a publicly traded, worldwide group. \u201cTechnology for Life\u201d is the guiding philosophy. Whether in the operating room, in intensive care, or emergency response services, Dr\u00e4ger products protect, support, and save lives.<\/p>\n

      For more information, please visit www.draeger.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Fisher & Paykel Healthcare Limited (Booth No: B04)<\/h4><\/div>

      Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea.<\/p>\n

      Established in New Zealand in 1969, our business was built on a vision to emulate the body\u2019s natural humidification processes. Today, our patented products and systems are used in 120 countries worldwide, impacting the lives of millions of patients every year. They enable patients to transition into less-acute care settings, recover more quickly and avoid more serious conditions.<\/p>\n

      For more information, please visit www.fphcare.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Fresenius Medical Care Ltd (Booth No: C03)<\/h4><\/div>

      As the world\u2019s leading provider of products and services for individuals with renal diseases, Fresenius Medical Care aims to continuously improve our patients\u2019 quality of life by offering them high-quality products as well as innovative technologies and treatment concepts. Our Critical Care division provides hospitals and ICUs with a comprehensive portfolio of technologies for the extracorporeal organ support of critically or otherwise severely ill patients, including acute blood puri\u2011cation, heart and lung support, and therapeutic apheresis.<\/p>\n

      For more information, please visit www.freseniusmedicalcare.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Hamilton Medical AG (Booth No: C06)<\/h4><\/div>

      Since our founding in 1983, Hamilton Medical has been committed to supporting medical teams in hospitals and beyond \u2014 with Intelligent Ventilation solutions designed to be safe, effective, and lung-protective. Our mission is to empower those who dedicate themselves every day to helping patients breathe and recover.<\/p>\n

      At APICS, discover how Hamilton Medical partners with healthcare professionals to advance the science and practice of mechanical ventilation. Through smart automation, real-time clinical decision support, and a steadfast commitment to innovation, we empower clinicians to deliver the best respiratory care \u2014 anytime, anywhere.<\/p>\n

      For more information, please visit www.hamilton-medical.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      HugeMed (Booth No: A07)<\/h4><\/div>

      Founded in 2014 and headquartered in the innovative city of Shenzhen, HugeMed is a national high-tech enterprise dedicated to the R&D, manufacturing, sales, and service of medical endoscopes. Over 10 years of development, our products have gained widespread recognition. In 2023, we were honored as a National \u201cLittle Giant\u201d SMEs by the China MIIT. This recognition aligns our growth with national policies, promising faster development opportunities.<\/p>\n

      HugeMed is one of China\u2019s leading exporters of Single-use endoscopes involves urology, pulmonology, anestheasiology, ENT, general surgery, etc.<\/p>\n

      Hugemed\u2019s products are exported to over 100 countries and regions. To date, our products are installed and sold in more than 6,000 medical institutions worldwide. As a supplier of anti-epidemic products, Hugemed contributed significantly to global healthcare systems during the pandemic. A scene in the film \u201cChinese Doctors\u201d depicting emergency intubation showcases the vital role of Hugemed\u2019s video laryngoscope during the crisis. Since entering the single-use endoscope market in 2018, our urology and respiratory products have seen robust growth.<\/p>\n

      For more information, please visit www.hugemed.net<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      ICUMEDICAL (Booth No: C07)<\/h4><\/div>

      ICU Medical is a global leader offering clinically essential products and solutions that connect patients with caregivers through life-enhancing, innovative technology and services that provide meaningful clinical value. Our robust portfolio features medical delivery systems and consumable products for infusion therapy, emergency medicine, general and regional anesthesia, homecare, NICU\/PICU, oncology, pain management, and respiratory care. We are a dedicated partner delivering leading-edge products across the continuum of care.<\/p>\n

      For more information, please visit: www.icumed.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      INSIGHTERS MEDICAL (Booth No: A05)<\/h4><\/div>

      Through insighting the pain points and demands from clinical physicians, Insighters Medical innovates the most leading airway management products in the world.<\/p>\n

      Today, as a leader in visualised airway management solutions, we invite you to visit our booth to explore our flagship products and discover our soon-to-be-launched innovations!<\/p>\n

      For more information, please visit\u00a0www.insighters.cn<\/span><\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Jafron Biomedical Co, Ltd (Booth No: C01)<\/h4><\/div>

      Jafron Biomedical Co., Ltd., founded in 2002, is the first ChiNext-listed company specialising in blood purification therapy in China (Stock Code: 300529). Jafron leverages proprietary resin hemoadsorption technology to provide comprehensive solutions for chronic renal and liver failure, intoxication, and autoimmune disorders, with applications further extending to sub-health interventions.<\/p>\n

      Today, our products are used in over 10,000 hospitals across more than 100 countries and regions worldwide, with reimbursement from national health insurance systems in 13 countries, including Germany, Italy, and Switzerland.<\/p>\n

      Through actively building a comprehensive blood purification ecosystem encompassing hemoperfusion equipment, consumables, pharmaceuticals, and CKD symptom management, Jafron aims to become a world-class high-tech medical technology enterprise.<\/p>\n

      For more information, please visit www.jafroninternational.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Lowenstein Medical SE & Co KG (Booth No: B03)<\/h4><\/div>

      The willingness to provide service, a pronounced customer proximity, and innovative strength in the development of new medical technologies are the decisive factors that have made Lowenstein Medical a leading medical technology company.<\/p>\n

      Lowenstein Medical is considered a pioneer and market leader for medical products in the hospital, homecare, and diagnostic sectors. Innovative technology, ergonomic design, and creative user interfaces characterise high-end systems and enable optimal support for the user in every situation. The success of \u201cMade in Germany\u201d products is based on excellent ideas, many years of experience, foresight, and innovation.<\/p>\n

      Since Reinhard Lowenstein joined the company in 1986, their core competence has been in the field of neonatology. Today\u2019s core competencies were developed from our expertise and knowledge of neonatology.<\/p>\n

      In the Hospital division, Lowenstein Medical offers ventilation solutions specially for newborns, anesthesia equipment, and intensive care ventilators for adults as well as children. In addition, the Homecare division was developed, which equips patients with supplies who require medical aids in their home environment. These aids are mainly used for the treatment of lung diseases or sleep-related respiratory disorders. The third and final division is Diagnostics, which aims to develop and market innovative products for the diagnosis of sleep-related breathing disorders.<\/p>\n

      Lowenstein Medical is there for you, from the initial diagnosis to hospitalisation to surgery or homecare. Our focus is on service \u2013 in all areas.<\/p>\n

      For more information, please visit www.loewensteinmedical.com<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      MACROLUX MEDICAL TECHNOLOGY CO, LTD (Booth No: A04)<\/h4><\/div>

      MacroLux Medical Technology Co., Ltd. was founded in Shenzhen, China\u2019s leading innovation hub. Its founding team comes from top-tier medical device companies, bringing extensive experience in endoscope research and development, manufacturing, and global sales.<\/p>\n

      Innovation sits at the core of MacroLux. Approximately 40% of its R&D team comprises senior experts from the endoscope industry, while specialists in optics, image optimisation, and mechanical engineering each bring an average of more than 15 years of industry experience.<\/p>\n

      The company operates a 9,000 m\u00b2 manufacturing facility equipped with a Class 100,000 cleanroom, a microbiology laboratory, a general production workshop, and comprehensive testing capabilities. MacroLux applies rigorous supplier evaluation processes and collaborative quality control systems, supported by intelligent tooling and real-time manufacturing monitoring to maintain precision and consistency.<\/p>\n

      Supported by more than five rounds of financing, MacroLux has achieved rapid growth and global commercialisation. Its products are distributed across Europe, North America, South America, and the Asia\u2013Pacific region, underpinned by long-term collaborations with clinical experts, medical institutions, and international distributors.<\/p>\n

      For more information, please visit www.microlite.cn<\/a><\/p>\n<\/div><\/div><\/div>

      <\/div><\/div><\/div><\/div><\/div>
      <\/div>
      <\/span><\/div><\/div><\/div>

      Pacific Medical Systems Ltd (Deltex) (Booth No: A02)<\/h4><\/div>

      At Deltex Medical, we\u2019re driven by a clear mission: to combat haemodynamic instability and help clinicians improve patient outcomes worldwide. As a global leader in advanced haemodynamic monitoring, we proudly partner anaesthetists and critical care specialists to reduce preventable complications and elevate standards of care.<\/p>\n

      Introducing TrueVue\u2122 \u2013 Advanced Insights. Better Outcomes.<\/strong><\/p>\n

      At the core of our innovation is TrueVue\u2122, the next generation in haemodynamic monitoring, built around our enhanced Oesophageal Doppler Monitoring (ODM) technology. TrueVue\u2122 integrates superior Doppler signal acquisition with Pulse Pressure Wave Analysis, providing comprehensive, real-time data for better informed clinical decisions.<\/p>\n

      Why TrueVue\u2122?<\/strong><\/p>\n